National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication
- PMID: 24308581
- DOI: 10.1586/14760584.2014.864563
National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication
Abstract
Achieving the goal of a world free of poliomyelitis still requires significant effort. Although polio immunization represents a mature area, the polio endgame will require new tools and strategies, particularly as national and global health leaders coordinate the cessation of all three serotypes of oral poliovirus vaccine and increasingly adopt inactivated poliovirus vaccine (IPV). Poliovirus epidemiology and the global options for managing polioviruses continue to evolve, along with our understanding and appreciation of the resources needed and the risks that require management. Based on insights from modeling, we offer some perspective on the current status of plans and opportunities to achieve and maintain a world free of wild polioviruses and to successfully implement oral poliovirus vaccine cessation. IPV costs and potential wastage will represent an important consideration for national policy makers. Innovations may reduce future IPV costs, but the world urgently needs lower-cost IPV options.
Similar articles
-
Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.Pediatrics. 2015 Jan;135(1):196-202. doi: 10.1542/peds.2014-3163. Pediatrics. 2015. PMID: 25548328
-
Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.J Infect Dis. 2014 Nov 1;210 Suppl 1:S485-97. doi: 10.1093/infdis/jit838. J Infect Dis. 2014. PMID: 25316871
-
Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.Expert Rev Vaccines. 2012 Apr;11(4):449-59. doi: 10.1586/erv.11.195. Expert Rev Vaccines. 2012. PMID: 22551030 Review.
-
Polio endgame: the global introduction of inactivated polio vaccine.Expert Rev Vaccines. 2015 May;14(5):749-62. doi: 10.1586/14760584.2015.1001750. Epub 2015 Jan 19. Expert Rev Vaccines. 2015. PMID: 25597843 Review.
-
Inactivated polio vaccine: time to introduce it in India's national immunization schedule.Hum Vaccin Immunother. 2012 Jul;8(7):956-8. doi: 10.4161/hv.20089. Epub 2012 Jun 15. Hum Vaccin Immunother. 2012. PMID: 22699444 Review.
Cited by
-
Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation.Gates Open Res. 2023 Apr 17;7:55. doi: 10.12688/gatesopenres.14511.1. eCollection 2023. Gates Open Res. 2023. PMID: 37547300 Free PMC article.
-
Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences.Risk Anal. 2024 Feb;44(2):366-378. doi: 10.1111/risa.14158. Epub 2023 Jun 21. Risk Anal. 2024. PMID: 37344934 Free PMC article. Review.
-
Cost-effectiveness of various immunization schedules with inactivated Sabin strain polio vaccine in Hangzhou, China.Front Public Health. 2022 Sep 23;10:990042. doi: 10.3389/fpubh.2022.990042. eCollection 2022. Front Public Health. 2022. PMID: 36211670 Free PMC article.
-
Economic evaluations of inactivated COVID-19 vaccines in six Western Pacific and South East Asian countries and regions: A modeling study.Infect Dis Model. 2022 Mar;7(1):109-121. doi: 10.1016/j.idm.2021.12.002. Epub 2021 Dec 10. Infect Dis Model. 2022. PMID: 34909514 Free PMC article.
-
Using integrated modeling to support the global eradication of vaccine-preventable diseases.Syst Dyn Rev. 2018 Jun;34(1-2):78-120. doi: 10.1002/sdr.1589. Syst Dyn Rev. 2018. PMID: 34552305 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
